Valuation: Navamedic ASA

Market Cap 385M 39.94M 34.9M 32.21M 29.69M 55.95M 3.85B 57.19M 385M 151M 1.88B 150M 147M 6.48B P/E 2026 *
-292x
P/E 2027 * 36.1x
Enterprise Value 505M 52.39M 45.78M 42.25M 38.94M 73.4M 5.05B 75.02M 505M 199M 2.47B 197M 192M 8.51B EV / Sales 2026 *
0.86x
EV / Sales 2027 * 0.73x
Free-Float
30.82%
Yield 2026 *
-
Yield 2027 * -
1 week-2.43%
Current month-1.83%
1 month-2.73%
3 months-22.84%
6 months-26.04%
Current year-32.56%
1 week 16.05
Extreme 16.05
16.65
1 month 15.7
Extreme 15.7
17.45
Current year 15.7
Extreme 15.7
24.5
1 year 15.7
Extreme 15.7
27.9
3 years 15.7
Extreme 15.7
43.9
5 years 15.7
Extreme 15.7
43.9
10 years 8.5
Extreme 8.5
43.9
Manager TitleAgeSince
Chief Executive Officer 60 01/01/2019
Director of Finance/CFO - 01/01/2026
Compliance Officer - -
Director TitleAgeSince
Director/Board Member 54 01/06/2022
Director/Board Member - 01/06/2023
Director/Board Member 60 01/06/2024
Date Insider Type Main position Quantity % Market Cap.
12/19/24 A Buy

Chief Operating Officer

10,267 0.0581%
9/9/24 A Fiscal year

Executive/Senior Manager

75,000 0.4302%
9/9/24 A Fiscal year

Chief Executive Officer

80,000 0.4589%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-2.43%-37.06%-57.76% 39.94M
+0.18%-0.98%+53.55%+152.32% 1,051B
-0.75%-2.51%+52.90%+49.25% 609B
-0.02%+2.40%+37.38%+78.60% 450B
-0.70%+0.42%+29.93%+21.29% 330B
-1.40%-1.14%+34.53%+35.42% 284B
-1.24%-1.30%+21.64%+16.36% 263B
-0.58%+0.83%-20.39%-40.75% 223B
-0.07%+1.60%+23.77%+57.01% 198B
-0.82%+1.63%+23.33%+67.05% 167B
Average -0.53%+0.27%+21.96%+37.88% 357.51B
Weighted average by Cap. -0.40%+0.02%+37.69%+72.79%

Financials

2026 *2027 *
Net sales 588M 60.99M 53.3M 49.19M 45.34M 85.45M 5.87B 87.35M 588M 231M 2.88B 229M 224M 9.9B 643M 66.76M 58.34M 53.84M 49.63M 93.54M 6.43B 95.61M 644M 253M 3.15B 251M 245M 10.84B
Net income -1.5M -155K -136K -125K -115K -217K -14.94M -222K -1.5M -588K -7.32M -583K -570K -25.19M 10.7M 1.11M 970K 895K 825K 1.56M 107M 1.59M 10.7M 4.21M 52.36M 4.17M 4.08M 180M
Net Debt 120M 12.45M 10.88M 10.04M 9.25M 17.44M 1.2B 17.83M 120M 47.2M 587M 46.76M 45.73M 2.02B 87.4M 9.07M 7.92M 7.31M 6.74M 12.7M 873M 12.99M 87.41M 34.38M 428M 34.06M 33.31M 1.47B
Logo Navamedic ASA
Navamedic ASA is a Norway-based pharmaceutical company. It is a supplier of products delivered to hospitals and pharmacies. Navamedic’s product portfolio consists of prescription and Over The Counter (OTC) pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. The Company’s offering is divided into four product areas: Consumer Health, Specialty Pharma, Medical Nutrition and Branded Generics. The Company has one business segment which is the Pharma division. Navamedic ASA is present in all Nordic countries, the Baltics and Benelux. The Company has two subsidiaries, Navamedic AB, through which the Company distributes more than 40 products and a Norway-based Novicus Pharma AS.
Employees
38
Date Price Change Volume
20/07/26 NOK 16.05 0.00% 8,428
17/07/26 NOK 16.05 0.00% 942
16/07/26 NOK 16.05 0.00% 10
15/07/26 NOK 16.05 -0.93% 2,151
14/07/26 NOK 16.20 -1.52% 5,258
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
16.05NOK
Average target price
23.50NOK
Spread / Average Target
+46.42%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NAVA Stock